Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 10,019 Shares

Key Points

• Director Robin Shane Readnour sold 10,019 shares of Anthem at an average price of $6.02, generating $60,314.38 and reducing his direct holdings by 1.76% to 557,990 shares. He also sold shares in two earlier transactions in August and September.
• Anthem shares rose 1.5% to $5.98, with a market capitalization of approximately $225.7 million. The company reported a quarterly loss of $0.18 per share.
• Institutional investors own 90.47% of the stock, while analyst opinions remain mixed; the consensus rating is Hold with a $9.00 target price.

Anthem, Inc. (NASDAQ:ANTX - Get Free Report) Director Robin Shane Readnour sold 10,019 shares of the company's stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $6.02, for a total transaction of $60,314.38. Following the sale, the director directly owned 557,990 shares in the company, valued at $3,359,099.80. This trade represents a 1.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Robin Shane Readnour also recently made the following trade(s):

• On Thursday, September 3rd, Robin Shane Readnour sold 6,100 shares of Anthem stock. The shares were sold at an average price of $6.07, for a total transaction of $37,027.00.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total transaction of $212,766.02.

Anthem Trading Up 1.5%

Shares of Anthem stock traded up $0.09 during trading on Tuesday, hitting $5.98. The stock had a trading volume of 335,287 shares, compared to its average volume of 213,148. The firm has a market cap of $225.69 million, a price-to-earnings ratio of -5.59 and a beta of -0.99. Anthem, Inc. has a 12 month low of $1.00 and a 12 month high of $7.19. The business's 50-day moving average is $5.33 and its 200 day moving average is $4.41.

Anthem (NASDAQ:ANTX - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) earnings per share (EPS) for the quarter.

Institutional Investors Weigh In On Anthem

Institutional investors have recently bought and sold shares of the stock. Citizens Financial Group Inc. RI purchased a new position in Anthem in the 2nd quarter worth approximately $1,443,000. ADAR1 Capital Management LLC purchased a new stake in shares of Anthem during the first quarter valued at approximately $47,000. OMERS ADMINISTRATION Corp bought a new position in shares of Anthem in the first quarter worth approximately $54,000. Velan Capital Investment Management LP bought a new position in shares of Anthem in the second quarter worth approximately $194,000. Finally, Seven Fleet Capital Management LP purchased a new position in shares of Anthem in the first quarter worth $683,000. 90.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Guggenheim started coverage on shares of Anthem in a research note on Monday, July 20th. They issued a "buy" rating and a $9.00 target price on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of Anthem in a research note on Monday, July 6th. Leerink Partners upgraded Anthem from a "market perform" rating to an "outperform" rating and set a $9.00 price objective for the company in a report on Thursday, May 14th. Finally, Wall Street Zen upgraded Anthem from a "sell" rating to a "hold" rating in a research report on Sunday, June 14th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $9.00.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.